Foothills Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-37,006
Closed -$2.49M 48
2015
Q2
$2.49M Sell
37,006
-1,690
-4% -$110K 2.1% 22
2015
Q1
$2.27M Buy
38,696
+698
+2% +$42.2K 1.84% 29
2014
Q4
$2.49M Buy
37,998
+11,897
+46% +$750K 2.04% 25
2014
Q3
$1.51M Sell
26,101
-348
-1% -$19.3K 1.23% 41
2014
Q2
$1.49M Buy
26,449
+125
+0.5% +$6.56K 1.15% 41
2014
Q1
$1.35M Sell
26,324
-390
-1% -$19.7K 1.1% 40
2013
Q4
$1.41M Buy
+26,714
New +$1.31M 1.17% 40

Other funds holding ABBV

Foothills Asset Management's ABBV Position: Q3 2015 in Review

Foothills Asset Management sold out of AbbVie (ABBV) in Q3 2015, closing a stake of 37,006 shares — an estimated $2.49M sold.

Foothills Asset Management first reported a position in ABBV in Q4 2013 and held it in 7 quarters. The position peaked at $2.49M in Q4 2014. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

  • Foothills Asset Management reported no remaining AbbVie position as of Q3 2015 after selling out during the quarter.
  • Foothills Asset Management sold 37,006 AbbVie shares in Q3 2015, an estimated $2.49M.
  • Foothills Asset Management first reported a position in AbbVie in Q4 2013 and held it in 7 quarters.
  • Foothills Asset Management's AbbVie position peaked at $2.49M in Q4 2014.
  • 1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Foothills Asset Management's 13F filing for Q3 2015, filed 19 Oct 2015.